Insights on ambulatory ECG monitoring in assessing risk of sudden cardiac death
Join us for a discussion with Dr. Martin Maron, Director of the Hypertrophic Cardiomyopathy Center (HCM) at Lahey Hospital & Medical Center. Dr. Maron will share recent data from an HCM center and research institute demonstrating the potential impact of longer ambulatory monitoring time in identifying a greater burden of non-sustained ventricular tachycardia (NSVT), which has potential implications on patient management.
In this webinar:
- Monitoring with Zio XT for 8-14 days vs. 3-7 days identified more NSVT (40% vs. 26%, respectively).1
- Case study illustrates two brands of ambulatory ECG patch monitors found significantly different burdens of NSVT.2
- Arrhythmia detection affected by monitor algorithm thresholds.3
Martin S. Maron, MD
Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital & Medical Center
Monitoring for 8-14 days vs. 3-7 days with Zio XT identified more clinically relevant arrhythmias.
Dr. Martin Maron discusses how the significant burden of NSVT identified through risk stratification using Zio XT influenced a primary prevention recommendation for a hypertrophic cardiomyopathy patient.
Watch the full webinar:
Center at Lahey Hospital & Medical Center
Dr. Martin Maron is Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital & Medical Center. His research interests are the diagnosis and management of hypertrophic cardiomyopathy, including identification of patients at high risk for sudden death as well as the role of cardiovascular magnetic resonance and ambulatory monitoring in assessment of patients with HCM and novel drug therapy to modify the disease. Dr. Maron has co-authored over 250 original publications on HCM including in The New England Journal of Medicine, The Lancet, Circulation, and Journal of the American College of Cardiology.
- Data on file. iRhythm Technologies, 2019.
- Individual facility results may vary.
- Fabrizio Guarracini et al. "Programming Optimization in Implantable Cardiac Monitors to Reduce False-Positive Arrhythmia Alerts: A Call for Research." Diagnostics, 2022. https://www.mdpi.com/2075-4418/12/4/994/htm